DR.REDDY'S LABORATORIES LTD. - ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.
Download
|
< Back
|
19 Apr 2016
|
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated April 19, 2016 titled "ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.".
|
View all announcements for DR.REDDY'S LABORATORIES LTD.
|
Source:
BSE India
|